| Literature DB >> 29858985 |
Klara Komici1, Grazia Daniela Femminella2, Claudio de Lucia3, Alessandro Cannavo2, Leonardo Bencivenga2, Graziamaria Corbi4, Dario Leosco2, Nicola Ferrara2,5, Giuseppe Rengo6,7.
Abstract
Diabetes mellitus (DM) and heart failure (HF) are frequent comorbidities among elderly patients. HF, a leading cause of mortality and morbidity worldwide, is characterized by sympathetic nervous system hyperactivity. The prevalence of diabetes mellitus (DM) is rapidly growing and the risk of developing HF is higher among DM patients. DM is responsible for several macro- and micro-angiopathies that contribute to the development of coronary artery disease (CAD), peripheral artery disease, retinopathy, neuropathy and diabetic nephropathy (DN) as well. Independently of CAD, chronic kidney disease (CKD) and DM increase the risk of HF. Individuals with diabetic nephropathy are likely to present a distinct pathological condition, defined as diabetic cardiomyopathy, even in the absence of hypertension or CAD, whose pathogenesis is only partially known. However, several hypotheses have been proposed to explain the mechanism of diabetic cardiomyopathy: increased oxidative stress, altered substrate metabolism, mitochondrial dysfunction, activation of renin-angiotensin-aldosterone system (RAAS), insulin resistance, and autonomic dysfunction. In this review, we will focus on the involvement of sympathetic system hyperactivity in the diabetic nephropathy.Entities:
Keywords: Adrenergic system; Diabetic nephropathy; GRK2; Heart failure
Mesh:
Year: 2018 PMID: 29858985 DOI: 10.1007/s40520-018-0973-2
Source DB: PubMed Journal: Aging Clin Exp Res ISSN: 1594-0667 Impact factor: 3.636